Saneca Pharmaceuticals a. s.

Active
IČO 46833323joint-stock company (a.s.)Founded 2012Hlohovec

Key figures

108 810 936 €+15,2%
Revenue 2025
+12,1%
Average annual growth 2020–2025
050 m100 m150 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 3 900 000 € (13 % of distributable profit).

History
20253 900 000 €
20240 €
2023 ~962 500 €
20220 €
20210 €

Summary: Saneca Pharmaceuticals a. s.

What kind of company is it?

Saneca Pharmaceuticals a. s. (IČO 46833323) is a joint-stock company (a.s.). The company was incorporated in 2012 and has existed for 14 years. Registered office according to the register: Hlohovec. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 1,000–1,999 employees.

Who runs the company and who owns it?

The statutory body has 3 members. The supervisory board has 3 members. The registered capital is 14 339 100 €.

How is the company doing financially?

Revenue for 2025 was 108 810 936 €, up 15,2 % on the previous year (94 470 137 €). From 2020 to 2025, revenue grew by an average of 12,1 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 12 080 065 € (11,1 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 34 758 556 €. At the end of 2025 the company had total assets of 118 135 266 € and equity of 55 180 084 € (equity ratio 46,7 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 21. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)61 382 55173 201 93085 943 50294 470 137108 810 936
Profit for the reporting year1 411 7321 678 2427 573 2599 904 00612 080 065
Retained earnings of previous periods10 570 59912 910 41212 688 65420 074 41325 893 099
Total assets71 615 11976 777 91783 899 50691 800 405118 135 266
Total liabilities43 338 44345 454 16846 415 87743 131 33259 872 483
Total equity26 952 33129 558 65436 169 41347 000 01955 180 084
Calculated dividends00962 50003 900 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a company to see its connections.

board of directorsboard of directorsboard of directorssupervisory boardsupervisory boardsupervisory boardfounderSaneca Pharmaceuticalsa. s.Saneca Pharmaceuticals a. s.ABIng. Alexandra BroszováIng. Alexandra BroszováMKIng. Matúš KutnýIng. Matúš KutnýRVRéka VilágiRéka VilágiFKFrantišek KudláčFrantišek KudláčRSIng. Róbert Spišák, PhD.Ing. Róbert Spišák, PhD.AKMgr. Adriana KadnárováMgr. Adriana Kadnárová
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements19

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 2120)
Saneca Pharmaceuticals a. s. (IČO 46833323) – revenue 109M €